Search Directory
native1_300x100
|
|---|
|
Columnists
Webcasts
Outsourcing
Adverse Event Reporting for Compounded Drugs
FDA issued a statement about the importance of reporting adverse events resulting from the use of compounded drugs.
Biologics Continue to Grow and Create Outsourcing Opportunities
CDMOs are adding facilities and services to their portfolios in anticipation of the biologics industry’s continued growth.
Lonza, Citryll Partner to Manufacture New NET Antibody
The new antibody, Citryll’s CIT-013, could offer new treatment options for various human diseases including lupus, vasculitis, pulmonary fibrosis, and organ damage due to sepsis.
